These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38220203)

  • 21. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels.
    Qi R; Fu R; Lei X; He J; Jiang Y; Zhang L; Wu Y; Wang S; Guo X; Chen F; Nie M; Yang M; Chen Y; Zeng J; Xu J; Xiong H; Fang M; Que Y; Yao Y; Wang Y; Cao J; Ye H; Zhang Y; Zheng Z; Cheng T; Zhang J; Lin X; Yuan Q; Zhang T; Xia N
    J Hepatol; 2024 May; 80(5):714-729. PubMed ID: 38336348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Escape mutants of hepatitis B virus].
    Jaramillo CM; Navas MC
    Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.
    Chen HB; Fang DX; Li FQ; Jing HY; Tan WG; Li SQ
    World J Gastroenterol; 2003 Feb; 9(2):304-8. PubMed ID: 12532454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
    Li H; Li GJ; Chen QY; Fang ZL; Wang XY; Tan C; Yang QL; Wang FZ; Wang F; Zhang S; Bi SL; Shen LP
    Epidemiol Infect; 2017 Apr; 145(5):887-894. PubMed ID: 28065199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
    PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China.
    Huang X; Lu D; Ji G; Sun Y; Ma L; Chen Z; Zhang L; Huang J; Yu L
    Virus Res; 2004 Jan; 99(1):63-8. PubMed ID: 14687948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.
    Su H; Zhang Y; Xu D; Wang B; Zhang L; Li D; Xiao D; Li F; Zhang J; Yan Y
    PLoS One; 2013; 8(8):e70768. PubMed ID: 23951004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor.
    Blaich A; Manz M; Dumoulin A; Schüttler CG; Hirsch HH; Gerlich WH; Frei R
    Transfusion; 2012 Sep; 52(9):1999-2006. PubMed ID: 22313146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine.
    Zhang C; Gong L; Chen Y; Wang X; Zhu S; Li D; Pang Y; Yin Y; Liu X; Zhu N
    Mol Immunol; 2013 Jan; 53(1-2):60-71. PubMed ID: 22809814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.
    Tarafdar S; Virata ML; Yan H; Zhong L; Deng L; Xu Y; He Y; Struble E; Zhang P
    J Med Virol; 2022 Feb; 94(2):649-658. PubMed ID: 34406663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.
    Ge G; Wang S; Han Y; Zhang C; Lu S; Huang Z
    PLoS One; 2012; 7(7):e41573. PubMed ID: 22844502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.
    Lehmann F; Slanina H; Roderfeld M; Roeb E; Trebicka J; Ziebuhr J; Gerlich WH; Schüttler CG; Schlevogt B; Glebe D
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
    Karthigesu VD; Allison LM; Ferguson M; Howard CR
    J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection.
    El-Mowafy M; Elegezy M; El-Mesery M; Elgaml A
    Virus Genes; 2024 Apr; 60(2):235-239. PubMed ID: 38349448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
    Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative characteristic of antigenic properties of recombinant and native hbs-antigens with G145R mutation and evaluation of their immunogenicity].
    Konopleva MV; Borisova VN; Sokolova MV; Feldsherova AA; Krymskij MA; Semenenko TA; Suslov AP
    Vopr Virusol; 2017; 62(4):179-186. PubMed ID: 29733168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current aspects of hepatitis B surface antigen mutants in Singapore.
    Oon CJ; Chen WN
    J Viral Hepat; 1998 Nov; 5 Suppl 2():17-23. PubMed ID: 9857356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.